Evidence map›Paper›PMID 37819930›Full record

ArticlePloS one2023

A live-cell platform to isolate phenotypically defined subpopulations for spatial multi-omic profiling.

Tala O Khatib, Angelica M Amanso, Christina M Knippler, Brian Pedro, Emily R Summerbell, Najdat M Zohbi, Jessica M Konen, Janna K Mouw, Adam I Marcus

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Tala O KhatibDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, United States of America.ORCID 0000-0003-3052-8474
Angelica M AmansoDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Christina M KnipplerDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Brian PedroDepartment of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.ORCID 0000-0003-1898-3458
Emily R SummerbellOffice of Intramural Training and Education, The National Institutes of Health, Bethesda, Maryland, United States of America.
Najdat M ZohbiGraduate Medical Education, Piedmont Macon Medical, Macon, Georgia, United States of America.
Jessica M KonenDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, United States of America.
Janna K MouwDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, United States of America.ORCID 0000-0002-9846-8466
Adam I MarcusDepartment of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, Georgia, United States of America.ORCID 0000-0003-0484-3569
Emory University · USJohns Hopkins University · USNational Institutes of Health · USNavicent Health · US

Funding

Winship Cancer Institute Cancer Center Support GrantP30CA138292 · NCI · EMORY UNIVERSITY · PI Ragini Reiney Kudchadkar · 2009 to 2026
$47.5M
Project 3: Inhibiting FAK to enhance immune checkpoint inhibitor therapy in LKB1-mutant lung adenocarcinomaP01CA257906 · NCI · EMORY UNIVERSITY · PI Yuan Liu · 2022 to 2026
$10.7M
Medical Scientist Training ProgramT32GM142617 · NIGMS · EMORY UNIVERSITY · PI Jason Yustein · 2022 to 2026
$7.0M
Training Program in Biochemistry, Cell and Molecular BiologyT32GM135060 · NIGMS · EMORY UNIVERSITY · PI Lawrence H. Boise, ANITA H. CORBETT · 2020 to 2026
$2.8M
Spatiotemporal interrogation of metabolic cooperation between heterogenous lung cancer subpopulations in collective cell invasionR01CA247367 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I., SHANMUGAM, MALATHY (MALA) · 2021 to 2025
$2.3M
Defining Early Escape Strategies in LKB1 Mutant Lung Cancer S1R01CA201340 · NCI · EMORY UNIVERSITY · PI GILBERT-ROSS, MELISSA, MARCUS, ADAM I. · 2016 to 2020
$2.0M
Atypical Angiogenic Mimicry During Collective Lung Cancer InvasionR01CA236369 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I. · 2019 to 2023
$1.8M
Deconstructing the collective invasion pack to define Myo10 functionR01CA250422 · NCI · EMORY UNIVERSITY · PI MARCUS, ADAM I. · 2020 to 2024
$1.8M
Deconstructing cellular heterogeneity and subpopulation cooperation in non-small cell lung cancer metastasisR50CA265345 · NCI · EMORY UNIVERSITY · PI MOUW, JANNA K · 2021 to 2025
$720k
NCI NIH HHS P01 CA257906NCI NIH HHS P30 CA138292NCI NIH HHS R01 CA201340NCI NIH HHS R01 CA236369NCI NIH HHS R01 CA247367NCI NIH HHS R01 CA250422NCI NIH HHS R50 CA265345NIGMS NIH HHS T32 GM135060NIGMS NIH HHS T32 GM142617
6 · The paper itself

Abstract

Numerous techniques have been employed to deconstruct the heterogeneity observed in normal and diseased cellular populations, including single cell RNA sequencing, in situ hybridization, and flow cytometry. While these approaches have revolutionized our understanding of heterogeneity, in isolation they cannot correlate phenotypic information within a physiologically relevant live-cell state with molecular profiles. This inability to integrate a live-cell phenotype-such as invasiveness, cell:cell interactions, and changes in spatial positioning-with multi-omic data creates a gap in understanding cellular heterogeneity. We sought to address this gap by employing lab technologies to design a detailed protocol, termed Spatiotemporal Genomic and Cellular Analysis (SaGA), for the precise imaging-based selection, isolation, and expansion of phenotypically distinct live cells. This protocol requires cells expressing a photoconvertible fluorescent protein and employs live cell confocal microscopy to photoconvert a user-defined single cell or set of cells displaying a phenotype of interest. The total population is then extracted from its microenvironment, and the optically highlighted cells are isolated using fluorescence activated cell sorting. SaGA-isolated cells can then be subjected to multi-omics analysis or cellular propagation for in vitro or in vivo studies. This protocol can be applied to a variety of conditions, creating protocol flexibility for user-specific research interests. The SaGA technique can be accomplished in one workday by non-specialists and results in a phenotypically defined cellular subpopulations for integration with multi-omics techniques. We envision this approach providing multi-dimensional datasets exploring the relationship between live cell phenotypes and multi-omic heterogeneity within normal and diseased cellular populations.

Indexed as

GenomicsMultiomicsCell CommunicationFlow CytometryPhenotype

Identifiers

PMID37819930
PMCPMC10566726
OpenAlexW4387526467

What Socratic holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.